These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33245640)

  • 1. Lymphocyte stimulation test in the diagnostics of adverse reactions to antituberculouse line 1 and 2 drugs.
    Averbakh MM; Kosmiadi GA; Andrievskay IY; Chernousova LN; Krushinskaya KA; Panova LV
    Klin Lab Diagn; 2020 Sep; 65(9):552-556. PubMed ID: 33245640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
    Suzuki Y; Miwa S; Shirai M; Ohba H; Murakami M; Fujita K; Suda T; Nakamura H; Hayakawa H; Chida K
    Chest; 2008 Nov; 134(5):1027-1032. PubMed ID: 18583516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years.
    Castro AT; Mendes M; Freitas S; Roxo PC
    Rev Port Pneumol (2006); 2015; 21(3):144-50. PubMed ID: 25926250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic review of anti-tuberculosis drug induced adverse reactions in China].
    Xia YY; Zhan SY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):419-23. PubMed ID: 17673012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The usefulness of lymphocyte stimulation test (LST) in side effects of antituberculosis drugs].
    Yano S; Kobayashi K; Kato K; Tatsukawa T; Shishido S
    Kekkaku; 2004 Jan; 79(1):7-10. PubMed ID: 14969082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin.
    Chan CH; Or KK; Cheung W; Woo J
    J Med; 1995; 26(1-2):43-52. PubMed ID: 7561530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.
    Schnippel K; Firnhaber C; Berhanu R; Page-Shipp L; Sinanovic E
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):393-398. PubMed ID: 29562986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.
    Mouton JP; Njuguna C; Kramer N; Stewart A; Mehta U; Blockman M; Fortuin-De Smidt M; De Waal R; Parrish AG; Wilson DPK; Igumbor EU; Aynalem G; Dheda M; Maartens G; Cohen K
    Medicine (Baltimore); 2016 May; 95(19):e3437. PubMed ID: 27175644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis.
    Schnippel K; Firnhaber C; Berhanu R; Page-Shipp L; Sinanovic E
    J Antimicrob Chemother; 2017 Jul; 72(7):1871-1879. PubMed ID: 28419314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors.
    Vilariça AS; Diogo N; André M; Pina J
    Rev Port Pneumol; 2010; 16(3):431-51. PubMed ID: 20635058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K; Wada M
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.
    Lehloenya RJ; Wallace J; Todd G; Dheda K
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1260-4. PubMed ID: 22747953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Drug Hypersensitivity Syndrome to Antituberculosis Drugs: A Case Report.
    Carneiro-Leão L; Gomes I; Freitas C; Costa E Silva M; Viseu R; Cernadas J
    J Investig Allergol Clin Immunol; 2020; 30(1):70-71. PubMed ID: 31530510
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antituberculosis Drug-Associated DRESS: A Case Series.
    Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
    J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
    Yee D; Valiquette C; Pelletier M; Parisien I; Rocher I; Menzies D
    Am J Respir Crit Care Med; 2003 Jun; 167(11):1472-7. PubMed ID: 12569078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs.
    Sun Q; Sha W; Gui XW; Xiao YJ; Zeng WH; Sun WW; Xiao HP; Ye WY
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):172-6. PubMed ID: 25863530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.